Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie M Randall

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|November 17, 2009
Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group studyShu-Yuan Liao, Kathleen M Darcy, Leslie M Randall, et al.
Gynecologic Oncology|July 30, 2020
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group studyKrishnansu S Tewari, Michael W Sill, Robert L Coleman, et al.
Gynecologic Oncology|September 28, 2010
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancerErnest S Han, Robert A Burger, Kathleen M Darcy, et al.
Gynecologic Oncology|June 10, 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White PaperLeslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator ProgramAngeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
Gynecologic Oncology|March 16, 2021
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundationBradley J Monk, Robert L Coleman, Thomas J Herzog, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancerRobert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
Future Oncology (London, England)|August 19, 2021
RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancerDavid M O'Malley, Leslie M Randall, Camille Gunderson Jackson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 5, 2025
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancerMario M Leitao, Kristin L Bixel, Dana Meredith Chase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)Janos L Tanyi, Leslie M Randall, Setsuko K Chambers, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|November 17, 2009
Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group studyShu-Yuan Liao, Kathleen M Darcy, Leslie M Randall, et al.
Gynecologic Oncology|July 30, 2020
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group studyKrishnansu S Tewari, Michael W Sill, Robert L Coleman, et al.
Gynecologic Oncology|September 28, 2010
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancerErnest S Han, Robert A Burger, Kathleen M Darcy, et al.
Gynecologic Oncology|June 10, 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White PaperLeslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator ProgramAngeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
Gynecologic Oncology|March 16, 2021
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundationBradley J Monk, Robert L Coleman, Thomas J Herzog, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 20, 2026
A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancerRobert M Wenham, Andrea L Buras, Sarah W Gordon, et al.
Future Oncology (London, England)|August 19, 2021
RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancerDavid M O'Malley, Leslie M Randall, Camille Gunderson Jackson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 5, 2025
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancerMario M Leitao, Kristin L Bixel, Dana Meredith Chase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006)Janos L Tanyi, Leslie M Randall, Setsuko K Chambers, et al.
Pageof 6